All product descriptions and articles provided on this website are intended strictly for informational and educational purposes. Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes). These compounds are not approved by the FDA for use in humans or animals. They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition. Any bodily administration-human or animal-is strictly prohibited by law. Our products are not for human consumption under any circumstances.
The study of pigmentation and melanocortin biology has gained significant traction over the past two decades. Melanotan II (MTII), a synthetic analogue of α-melanocyte-stimulating hormone (α-MSH), is one of the most widely investigated compounds in this field. MTII acts on melanocortin receptors, particularly MC1R, to stimulate melanogenesis and influence pigmentation responses.
Unlike naturally occurring α-MSH, MTII has enhanced potency and stability due to its cyclic peptide structure, making it an effective research tool in cell culture and animal models. Researchers have employed MTII (commonly provided in 10 mg vials for laboratory use) to investigate pigmentation, photoprotection, appetite regulation, and sexual function pathways.
Mechanism of Action and Pigmentation Effects
MTII mimics the natural effects of α-MSH by binding to melanocortin-1 receptors (MC1R) on melanocytes. Upon activation, MC1R stimulates the cyclic AMP (cAMP) pathway, which in turn activates protein kinase A (PKA). PKA phosphorylates the transcription factor CREB, leading to upregulation of MITF (microphthalmia-associated transcription factor). MITF regulates key melanogenic enzymes such as tyrosinase (TYR), TYRP1, and DCT, driving eumelanin production.
- Enhanced eumelanogenesis: Studies have confirmed that MTII preferentially increases eumelanin over pheomelanin[1], which provides superior UV absorption and protection against DNA damage.
- Photoprotective pigmentation: Activation of MC1R by MTII enhances melanosome transfer to keratinocytes, a crucial step for visible skin pigmentation and photoprotection. Virador et al. (2002)[2] showed that α-MSH significantly increases melanosome transfer, an effect replicated with MTII.
- Potency and stability: Unlike α-MSH, which has a short half-life, MTII is more resistant to enzymatic degradation[3], making it useful in long-term in-vitro studies.
Reported Benefits in Research
Research into Melanotan II has expanded beyond pigmentation, with multiple studies documenting secondary effects and promising therapeutic leads:
1. Photoprotection and DNA Repair
Research indicates that MC1R signaling stimulated by MTII is linked to enhanced nucleotide excision repair (NER) and reduced UV-induced DNA mutations. Studies[4] demonstrated that melanocortin activation supports genome stability, making MTII an important model compound for studying DNA repair pathways.
2. Appetite and Weight Regulation
Early studies showed MTII’s influence on MC4R receptors in the hypothalamus, where it reduced food intake and promoted weight loss in preclinical models. Dorr et al. (1996) also observed reduced appetite in human pharmacology studies, suggesting potential applications for obesity research.
3. Sexual Function Studies
MTII’s activation of melanocortin receptors beyond MC1R has been associated with erectogenic effects. Early trials reported spontaneous erections in male subjects, leading to the development of bremelanotide (PT-141) as a derivative for sexual dysfunction research.
4. Anti-Inflammatory and Tumor Modulation
According to studies it is reported that topical MTII reduced melanoma progression in mice by upregulating PTEN and suppressing AKT/NF-κB/COX-2/PGE₂ signaling. These findings suggest that MTII can modulate not only pigmentation but also inflammation and tumor biology, offering broader research utility.
Experimental Data and Trials
In Vitro Studies
- Concentration ranges: B16-F10 melanoma cell studies show MTII activity across 0.1 nM–1 µM, with strong responses at ~10 nM. Assays revealed increased melanin content, tyrosinase activity, and enhanced cell migration compared to untreated controls.
Benchmarking with α-MSH: Scientists[5] used 200 nM α-MSH as a positive control for melanogenesis. MTII, being more potent, achieves similar or greater responses at lower concentrations.
Animal Studies
-
In murine models, systemic and topical MTII administration led to rapid pigmentation within days and offered protection against UV-induced DNA damage.
Human Trials (Historical Research)
-
Clinical trials[6] were conducted, on one of the earliest human studies, showing that MTII induced noticeable tanning and influenced appetite and erectile function. While not approved for therapy, these findings highlight MTII’s multifaceted biological effects.
Applications in Research
MTII is widely used to study melanoma suppression, skin pigmentation, appetite regulation, and inflammatory pathways, making it a valuable tool in oncology, dermatology, neuroscience, and immunology research. To better understand its impact, let’s explore these applications in detail:
- Pigmentation biology: Useful for quantifying melanin synthesis, tyrosinase activity, and melanosome transfer in melanocyte models.
- Photoprotection research: Helps assess DNA repair pathways, NER efficiency, and pigmentation-dependent UV resistance.
- Metabolic studies: Provides a model for understanding appetite regulation and hypothalamic melanocortin receptor signaling.
- Oncology: Investigated for its effects on melanoma progression, tumor microenvironment, and inflammatory signaling.
-
Endocrinology and neurology: Its impact on MC4R makes it relevant for studies in sexual health and neuroendocrine signaling.
Safety Notes (Why for Research Use Only)
While MTII shows clear benefits in controlled studies, it is not approved for therapeutic or cosmetic use. Case reports describe nevus darkening, eruptive moles, and even melanoma associated with unregulated self-administration. Lee et al. (2009) and other reports underscore the importance of restricting MTII to laboratory settings.
Regulatory bodies including the FDA and TGA classify MTII as unapproved and warn against its commercial sale for human use. For researchers, this emphasizes the need to treat MTII strictly as a laboratory reagent.
Advance Pigmentation Research with Prime Lab Peptides: Power Your Discoveries with Melanotan II
Researchers often struggle with unstable compounds, inconsistent results, and limited access to reliable analogues when exploring pigmentation biology, DNA repair, or melanocortin signaling. These challenges slow progress, create gaps in reproducibility, and make it difficult to translate lab findings into meaningful insights. On top of this, safety concerns around unverified sources can jeopardize both research integrity and outcomes.
Prime Lab Peptides provides researchers with high-quality, lab-grade Melanotan II designed for consistency, stability, and reliability. By supplying compounds manufactured to rigorous standards, we help scientists overcome barriers to reproducibility and safety. With Prime Lab Peptides, you gain the confidence to push your pigmentation and melanocortin studies forward, knowing every vial supports accurate, responsible, and groundbreaking discoveries.
References
3- ScienceDirect. Melanotan II – an overview. ScienceDirect.
